Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

Kyle J. Gaulton (Lead / Corresponding author), Teresa Ferreira, Yeji Lee, Anne Raimondo, Reedik Mägi, Michael E. Reschen, Anubha Mahajan, Adam Locke, N. William Rayner, Neil Robertson, Robert A. Scott, Inga Prokopenko, Laura J. Scott, Todd Green, Thomas Sparso, Dorothee Thuillier, Loic Yengo, Harald Grallert, Simone Wahl, Mattias FrånbergRona J. Strawbridge, Hans Kestler, Himanshu Chheda, Lewin Eisele, Stefan Gustafsson, Valgerdur Steinthorsdottir, Gudmar Thorleifsson, Lu Qi, Lennart C. Karssen, Elisabeth M. van Leeuwen, Sara M. Willems, Man Li, Han Chen, Christian Fuchsberger, Phoenix Kwan, Clement Ma, Michael Linderman, Yingchang Lu, Soren K. Thomsen, Jana K. Rundle, Nicola L. Beer, Martijn van de Bunt, Anil Chalisey, Hyun Min Kang, Benjamin F. Voight, Alex S. F. Doney, Andrew D. Morris, Colin N. A. Palmer, DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium

    Research output: Contribution to journal › Article › peer-review

    296 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci'. Together they form a unique fingerprint.

    Medicine & Life Sciences